Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.
Identifieur interne : 001D89 ( Main/Exploration ); précédent : 001D88; suivant : 001D90Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.
Auteurs : Sibel Eyigör [Oman] ; Ece Cinar ; Ismail Caramat ; Burcu Koc UnluSource :
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [ 1433-7339 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Antinéoplasiques hormonaux (usage thérapeutique), Bras (physiopathologie), Femelle, Humains, Lymphoedème (), Lymphoedème (physiopathologie), Lymphoedème (traitement médicamenteux), Période postopératoire, Sujet âgé, Tamoxifène (usage thérapeutique), Tumeurs du sein (), Tumeurs du sein (physiopathologie), Tumeurs du sein (traitement médicamenteux), Études rétrospectives.
- MESH :
- physiopathologie : Bras, Lymphoedème, Tumeurs du sein.
- traitement médicamenteux : Lymphoedème, Tumeurs du sein.
- usage thérapeutique : Antinéoplasiques hormonaux, Tamoxifène.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Lymphoedème, Période postopératoire, Sujet âgé, Tumeurs du sein, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Antineoplastic Agents, Hormonal (therapeutic use), Arm (physiopathology), Breast Neoplasms (complications), Breast Neoplasms (drug therapy), Breast Neoplasms (physiopathology), Female, Humans, Lymphedema (complications), Lymphedema (drug therapy), Lymphedema (physiopathology), Middle Aged, Postoperative Period, Retrospective Studies, Tamoxifen (therapeutic use).
- MESH :
- chemical , therapeutic use : Antineoplastic Agents, Hormonal, Tamoxifen.
- complications : Breast Neoplasms, Lymphedema.
- drug therapy : Breast Neoplasms, Lymphedema.
- physiopathology : Arm, Breast Neoplasms, Lymphedema.
- Adult, Aged, Female, Humans, Middle Aged, Postoperative Period, Retrospective Studies.
Abstract
In clinical practice, noticeable differences are seen in patient response to the treatment of breast cancer-related lymphedema. Although some factors influencing response to treatment are mentioned in the literature, there is no sufficient evidence and results are confusing. For this reason, our objective in this study is to identify predictive and response-related factors for response to treatment of breast cancer-related lymphedema.
DOI: 10.1007/s00520-015-2633-9
PubMed: 25663541
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001060
- to stream PubMed, to step Curation: 001060
- to stream PubMed, to step Checkpoint: 001060
- to stream Ncbi, to step Merge: 007008
- to stream Ncbi, to step Curation: 007008
- to stream Ncbi, to step Checkpoint: 007008
- to stream Main, to step Merge: 001D92
- to stream Main, to step Curation: 001D89
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.</title><author><name sortKey="Eyigor, Sibel" sort="Eyigor, Sibel" uniqKey="Eyigor S" first="Sibel" last="Eyigör">Sibel Eyigör</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine Physical Therapy and Rehabilitation Department, Tulay Aktas Oncology Hospital, Supportive Care Unit, Ege University, Bornova, 35100, Izmir, Turkey, eyigor@hotmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Faculty of Medicine Physical Therapy and Rehabilitation Department, Tulay Aktas Oncology Hospital, Supportive Care Unit, Ege University, Bornova, 35100, Izmir, Turkey</wicri:regionArea><wicri:noRegion>Turkey</wicri:noRegion></affiliation></author><author><name sortKey="Cinar, Ece" sort="Cinar, Ece" uniqKey="Cinar E" first="Ece" last="Cinar">Ece Cinar</name></author><author><name sortKey="Caramat, Ismail" sort="Caramat, Ismail" uniqKey="Caramat I" first="Ismail" last="Caramat">Ismail Caramat</name></author><author><name sortKey="Unlu, Burcu Koc" sort="Unlu, Burcu Koc" uniqKey="Unlu B" first="Burcu Koc" last="Unlu">Burcu Koc Unlu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25663541</idno><idno type="pmid">25663541</idno><idno type="doi">10.1007/s00520-015-2633-9</idno><idno type="wicri:Area/PubMed/Corpus">001060</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001060</idno><idno type="wicri:Area/PubMed/Curation">001060</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001060</idno><idno type="wicri:Area/PubMed/Checkpoint">001060</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001060</idno><idno type="wicri:Area/Ncbi/Merge">007008</idno><idno type="wicri:Area/Ncbi/Curation">007008</idno><idno type="wicri:Area/Ncbi/Checkpoint">007008</idno><idno type="wicri:Area/Main/Merge">001D92</idno><idno type="wicri:Area/Main/Curation">001D89</idno><idno type="wicri:Area/Main/Exploration">001D89</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.</title><author><name sortKey="Eyigor, Sibel" sort="Eyigor, Sibel" uniqKey="Eyigor S" first="Sibel" last="Eyigör">Sibel Eyigör</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine Physical Therapy and Rehabilitation Department, Tulay Aktas Oncology Hospital, Supportive Care Unit, Ege University, Bornova, 35100, Izmir, Turkey, eyigor@hotmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Faculty of Medicine Physical Therapy and Rehabilitation Department, Tulay Aktas Oncology Hospital, Supportive Care Unit, Ege University, Bornova, 35100, Izmir, Turkey</wicri:regionArea><wicri:noRegion>Turkey</wicri:noRegion></affiliation></author><author><name sortKey="Cinar, Ece" sort="Cinar, Ece" uniqKey="Cinar E" first="Ece" last="Cinar">Ece Cinar</name></author><author><name sortKey="Caramat, Ismail" sort="Caramat, Ismail" uniqKey="Caramat I" first="Ismail" last="Caramat">Ismail Caramat</name></author><author><name sortKey="Unlu, Burcu Koc" sort="Unlu, Burcu Koc" uniqKey="Unlu B" first="Burcu Koc" last="Unlu">Burcu Koc Unlu</name></author></analytic><series><title level="j">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</title><idno type="eISSN">1433-7339</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antineoplastic Agents, Hormonal (therapeutic use)</term><term>Arm (physiopathology)</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (physiopathology)</term><term>Female</term><term>Humans</term><term>Lymphedema (complications)</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (physiopathology)</term><term>Middle Aged</term><term>Postoperative Period</term><term>Retrospective Studies</term><term>Tamoxifen (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antinéoplasiques hormonaux (usage thérapeutique)</term><term>Bras (physiopathologie)</term><term>Femelle</term><term>Humains</term><term>Lymphoedème ()</term><term>Lymphoedème (physiopathologie)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Période postopératoire</term><term>Sujet âgé</term><term>Tamoxifène (usage thérapeutique)</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (physiopathologie)</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents, Hormonal</term><term>Tamoxifen</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Bras</term><term>Lymphoedème</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Arm</term><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphoedème</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques hormonaux</term><term>Tamoxifène</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Postoperative Period</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Lymphoedème</term><term>Période postopératoire</term><term>Sujet âgé</term><term>Tumeurs du sein</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In clinical practice, noticeable differences are seen in patient response to the treatment of breast cancer-related lymphedema. Although some factors influencing response to treatment are mentioned in the literature, there is no sufficient evidence and results are confusing. For this reason, our objective in this study is to identify predictive and response-related factors for response to treatment of breast cancer-related lymphedema.</div></front></TEI><affiliations><list><country><li>Oman</li></country></list><tree><noCountry><name sortKey="Caramat, Ismail" sort="Caramat, Ismail" uniqKey="Caramat I" first="Ismail" last="Caramat">Ismail Caramat</name><name sortKey="Cinar, Ece" sort="Cinar, Ece" uniqKey="Cinar E" first="Ece" last="Cinar">Ece Cinar</name><name sortKey="Unlu, Burcu Koc" sort="Unlu, Burcu Koc" uniqKey="Unlu B" first="Burcu Koc" last="Unlu">Burcu Koc Unlu</name></noCountry><country name="Oman"><noRegion><name sortKey="Eyigor, Sibel" sort="Eyigor, Sibel" uniqKey="Eyigor S" first="Sibel" last="Eyigör">Sibel Eyigör</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25663541
|texte= Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25663541" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |